Ozempic’s Popularity Wanes: What’s Next for the Weight Loss Drug?
Based on the provided web search results, hear’s a thorough reply: Novo Nordisk reported strong financial performance for the full year 2024. The company saw its sales grow by 26% at constant exchange rates to $40.5 billion, driven significantly by the demand for its diabetes and obesity treatments, especially Ozempic and Wegovy [1[1[1[1]. The operating … Read more